P/E at 65.7 vs Industry's 66.3: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Slight Discount in a High-P/E Sector

The hospital industry currently commands a lofty average P/E of 66.29, reflecting elevated investor expectations for growth and profitability in the healthcare space. Against this backdrop, Apollo Hospitals Enterprise Ltd. trades at a P/E of 65.71, marginally below the sector average. This subtle discount suggests that the market is pricing in a valuation close to peers but with a slight cautionary tilt. Given the sector’s premium valuations, the data implies that investors are not assigning a significant valuation premium to the company despite its large-cap stature and market leadership. Apollo Hospitals’s valuation thus reflects a balance between growth prospects and risk factors inherent in the hospital industry.

Performance Across Timeframes: Strong Long-Term Gains with Recent Stability

Examining returns over various periods reveals a compelling growth trajectory for Apollo Hospitals. The stock has delivered a robust 67.44% gain over three years and an impressive 121.56% over five years, significantly outperforming the Sensex’s respective 17.14% and 47.18% returns. Over a decade, the stock’s appreciation of 558.25% dwarfs the Sensex’s 176.26%, underscoring its long-term value creation.

In the more recent past, the stock’s year-to-date return of 27.05% contrasts sharply with the Sensex’s decline of 9.06%, highlighting resilience amid broader market weakness. The three-month return of 16.14% also outperforms the Sensex’s flat performance, while the one-month gain of 3.33% exceeds the Sensex’s 1.00% rise. However, the one-week and one-day returns of 0.11% and 0.47% respectively lag behind the Sensex’s 0.97% and 0.95%, indicating a slight loss of short-term momentum. This divergence between longer-term strength and recent short-term softness raises questions about the sustainability of the current rally — is this a pause before further gains or a signal of near-term consolidation?

Moving Average Configuration: Bullish Across All Key Averages

The technical picture for Apollo Hospitals is notably positive. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a strong upward trend across both short and long-term horizons. This comprehensive bullish configuration suggests that the stock has overcome recent resistance levels and is maintaining momentum. The fact that it is just 0.66% shy of its 52-week high of ₹9,008.9 further reinforces the strength of the current uptrend.

Moreover, the stock has recorded gains for three consecutive days, accumulating a 1.65% rise in that period. This short-term positive streak, combined with the moving average alignment, points to a sustained recovery phase rather than a fleeting bounce — is this momentum likely to continue or face resistance near all-time highs?

Sector Performance Context: Hospital Industry Remains Elevated

The hospital sector continues to command high valuations, with an industry P/E of 66.29 reflecting investor confidence in healthcare demand and earnings growth. Within this environment, Apollo Hospitals stands as a large-cap leader with a market capitalisation of ₹1,28,657.07 crore. The sector’s performance has been mixed recently, with some stocks experiencing volatility amid regulatory and operational challenges. However, the overall trend remains positive, supported by rising healthcare expenditure and expanding service offerings.

In this context, Apollo Hospitals’s ability to maintain a valuation close to the sector average while delivering superior returns over multiple timeframes highlights its relative strength. The stock’s outperformance year-to-date and over the past three months contrasts with some sector peers that have struggled to sustain momentum — how does this relative resilience affect the company’s positioning within the hospital sector?

Rating Reassessment: Previously Hold, Now Updated

MarketsMOJO had previously rated Apollo Hospitals Enterprise Ltd. as Hold. The rating was reassessed on 11 May 2026, reflecting updated analysis of the company’s fundamentals, valuation, and technicals. While the current rating is not disclosed, the reassessment coincides with the stock’s strong performance across multiple timeframes and its favourable moving average configuration. This suggests a reconsideration of the company’s investment profile in light of recent data.

Given the stock’s premium valuation relative to the broader market but slight discount to its sector, alongside its consistent gains and technical strength, the rating update appears to factor in a nuanced balance of risk and reward. Should investors in Apollo Hospitals hold, buy more, or reconsider? The current rating provides the answer.

Conclusion: Data Reflects a Balanced Valuation with Strong Momentum

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a valuation closely aligned with its sector peers, yet delivering superior returns over multiple timeframes. The slight discount in P/E relative to the industry average suggests measured investor expectations, while the stock’s consistent outperformance versus the Sensex highlights its resilience.

Technically, the stock’s position above all major moving averages and proximity to its 52-week high indicate a robust uptrend. The recent rating reassessment from Hold to an updated status reflects this evolving profile, balancing valuation, performance, and technical factors. What does the current rating imply for investors navigating this complex valuation-performance landscape?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →